Search Results for: anticipated spike

Ahead of receipt of anticipated CE Mark, European customers can begin requesting DaVitri to expand patient access to high-quality IVF MADRID–(BUSINESS WIRE)–Overture Life, the innovator modernizing IVF to optimize reproductive freedom, today announced the launch of its European preorder waitlist for DaVitri, the world’s first automated vitrification platform. The waitlist ensures in vitro fertilization (IVF) … [Read more…]

AstroZhi launches its VitaZhi range of dietary supplements, available now online and in select health food stores from May. KILKENNY, Ireland–(BUSINESS WIRE)–AstroZhi, a pioneer in scientific research-backed dietary supplements, has announced a groundbreaking development in healthcare with the introduction of specialised products aimed at aiding in the recovery from long-COVID syndrome. This long-anticipated move positions … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Temperature-Controlled Packaging for the Pharmaceutical Market” report has been added to ResearchAndMarkets.com’s offering. Pharmaceutical Temperature-Controlled Packaging Market is projected to reach a value of $16.8 billion by 2028 from $10.6 billion in 2023, growing at a CAGR of 9.5%. This research report incorporates an in-depth analysis of the global temperature-controlled packaging market, including … [Read more…]

TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotechnology company dedicated to fighting infectious diseases including COVID-19, announces that Kim Murphy, Chief Executive Officer, will be participating in the World Vaccine Congress Washington, being held April 3-6, 2023, in Washington, D.C. Ms. Murphy will be holding meetings to highlight the company’s … [Read more…]

The target Prescription Drug User Fee Act (PDUFA) action date for a decision by the FDA is May 2023 NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted 16 to 1 that available data support the safety and effectiveness of PAXLOVID™ (nirmatrelvir … [Read more…]

BURLINGTON, Ontario–(BUSINESS WIRE)–On Friday, January 27, 2023, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), filed its financial results for the fiscal year ended February 28, 2022. Now that the Company has completed the filing of its audited financial statements for the fiscal year ended February 28, 2022 as well as its interim … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Vaccines Market – Global Industry Analysis (2019 – 2021), Growth Trends, and Market Forecast (2023 – 2029)” report has been added to ResearchAndMarkets.com’s offering. Escalating investments by vaccine manufacturers, and governments from across the globe is predominantly driving the global vaccines market growth. This US$90 Bn market (2021) is projected to reach the … [Read more…]

Tevogen Bio CEO and CSO share concerns of the White House and President Joe Biden who stated, “New variants may make some existing protections ineffective for the immunocompromised” and promise to do everything in their power to accelerate development and manufacturing of its investigational therapy, TVGN-489 A comprehensive review by the company’s R&D team found … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Preclinical Medical Device Testing Services Market by Service (Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing, Package Validation), by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global preclinical medical device testing services market share is expected to reach USD 4.9 billion by 2030, according to this report. … [Read more…]

This phase 2 trial evaluates the safety, tolerability, and immunogenicity of Covigenix VAX-001-1b in healthy adults 18 years and older A total of 268 participants have been enrolled in the study at two sites in Burkina Faso, completing the single and two-dose cohorts EDMONTON, Alberta & OUAGADOUGOU, Burkina Faso–(BUSINESS WIRE)–Entos Pharmaceuticals (Entos), a clinical-stage biotechnology … [Read more…]